We are live on ! Find out more
CRVO icon

CervoMed
CRVO

45 hedge funds and large institutions have $13.7M invested in CervoMed in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 18 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.27% less ownership

Funds ownership: 26.24% → 24.97% (-1.3%)

6% less funds holding

Funds holding: 48 → 45 (-3)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

35% less capital invested

Capital invested by funds: $20.9M → $13.7M (-$7.24M)

61% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 18

Holders
45
Holders Change
-3
Holders Change %
-6.25%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
7
Reduced
18
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.03M
2
Millennium Management
Millennium Management
New York
+$648K
3
Jane Street
Jane Street
New York
+$562K
4
Goldman Sachs
Goldman Sachs
New York
+$181K
5
TDC
Thompson Davis & Co
Virginia
+$119K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.08M
2
State Street
State Street
Massachusetts
-$794K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$530K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$329K
5
N
Nuveen
North Carolina
-$312K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$14K +$18K +2,111 +1,193%
HI
27
Hoey Investments
Pennsylvania
$6.79K – – –
Citigroup
28
Citigroup
New York
$6.04K -$24.6K -2,884 -75%
CIAM
29
Caitong International Asset Management
Hong Kong
$5.69K -$5.99K -703 -44%
Bank of America
30
Bank of America
North Carolina
$5.53K -$23.7K -2,785 -76%
Carson Wealth (CWM LLC)
31
Carson Wealth (CWM LLC)
Nebraska
$5K -$844 -99 -11%
WOSD
32
WFA of San Diego
California
$4.56K +$6.18K +725 New
Barclays
33
Barclays
United Kingdom
$2.62K -$46.6K -5,464 -93%
SS
34
SBI Securities
Japan
$1.74K +$537 +63 +29%
Nisa Investment Advisors
35
Nisa Investment Advisors
Missouri
$1.58K – – –
PS
36
Principal Securities
Iowa
$1.04K +$1.41K +165 New
Wells Fargo
37
Wells Fargo
California
$823 -$20.9K -2,448 -95%
BNP Paribas Financial Markets
38
BNP Paribas Financial Markets
France
$597 -$1.61K -189 -67%
APW
39
Aventura Private Wealth
Florida
$427 – – –
EWA
40
EverSource Wealth Advisors
Alabama
$226 – – –
Osaic Holdings
41
Osaic Holdings
Arizona
$187 +$111 +13 +76%
EP
42
Essential Partners
California
$44 +$60 +7 New
TWD
43
True Wealth Design
Ohio
$32 +$9 +1 +25%
MWA
44
Medallion Wealth Advisors
Connecticut
$12 – – –
DB
45
Danske Bank
Denmark
$6 – – –
N
46
Nuveen
North Carolina
– -$312K -34,099 Closed
Charles Schwab
47
Charles Schwab
California
– -$116K -12,722 Closed
Bank of New York Mellon
48
Bank of New York Mellon
New York
– -$110K -12,028 Closed
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
– -$53.3K -5,830 Closed
Mirae Asset Global ETFs Holdings
50
Mirae Asset Global ETFs Holdings
Hong Kong
– -$30.3K -3,314 Closed
1
2
3

CRVO Hedge Fund Activity: Q2 2025 in Review

45 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2025, worth a combined $13.7M — down 35% from $20.9M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CRVO and 11 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 7 added.

The largest buyer was Morgan Stanley, adding an estimated $2.03M. The largest seller was BlackRock, cutting an estimated $2.08M.

  • 45 institutional investors held CervoMed (CRVO) as of Q2 2025, down from 48 in Q1 2025.
  • Funds reported $13.7M of CervoMed stock for Q2 2025, down 35% quarter-over-quarter.
  • 11 funds opened new CervoMed positions in Q2 2025 and 14 closed out, a net change of -3 holders.
  • The largest CervoMed buyer in Q2 2025 was Morgan Stanley, an estimated $2.03M added.
  • The largest CervoMed seller in Q2 2025 was BlackRock, an estimated $2.08M sold.

Based on aggregated 13F filings for Q2 2025.